Breathe Biologics
is a regenerative medicine company focused on lung diseases using our licensed and patented umbilical cord derived mesenchymal stem cell, termed “JadiCell™”
COPD is a consistently progressive, ultimately fatal disease.
15.7
million Americans (6.4%) reported that they have been diagnosed with COPD
50%
of adults with low pulmonary function were not aware that they had COPD
3.23
million deaths worldwide in 2019. COPD is the third leading cause of death worldwide
90%
of COPD deaths in those under 70 years of age occur in low- and middle-income countries
7th
leading cause of poor health worldwide is COPD
70%
of COPD is smoking related in high-income countries
JadiCell Therapy for COPD IND # 28508
To determine safety and efficacy of intravenously administered allogeneic JadiCell umbilical cord blood mesenchymal stem cells in patients with moderate-to-severe COPD.